MiR-205 Is Progressively Down-Regulated in Lymph Node Metastasis but Fails as a Prognostic Biomarker in High-Risk Prostate Cancer
Open Access
- 29 October 2013
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (11), 21414-21434
- https://doi.org/10.3390/ijms141121414
Abstract
The treatment of high-risk prostate cancer (HRPCa) is a tremendous challenge for uro-oncologists. The identification of predictive moleculobiological markers allowing risk assessment of lymph node metastasis and systemic progression is essential in establishing effective treatment. In the current study, we investigate the prognostic potential of miR-205 in HRPCa study and validation cohorts, setting defined clinical endpoints for both. We demonstrate miR-205 to be significantly down-regulated in over 70% of the HRPCa samples analysed and that reconstitution of miR-205 causes inhibition of proliferation and invasiveness in prostate cancer (PCa) cell lines. Additionally, miR-205 is increasingly down-regulated in lymph node metastases compared to the primary tumour indicating that miR-205 plays a role in migration of PCa cells from the original location into extraprostatic tissue. Nevertheless, down-regulation of miR-205 in primary PCa was not correlated to the synchronous presence of metastasis and failed to predict the outcome for HRPCa patients. Moreover, we found a tendency for miR-205 up-regulation to correlate with an adverse outcome of PCa patients suggesting a pivotal role of miR-205 in tumourigenesis. Overall, we showed that miR-205 is involved in the development and metastasis of PCa, but failed to work as a useful clinical biomarker in HRPCa. These findings might have implications for the use of miR-205 as a prognostic or therapeutic target in HRPCa.This publication has 35 references indexed in Scilit:
- MiR-205 in cancer: An angel or a devil?European Journal of Cell Biology, 2013
- Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancerProceedings of the National Academy of Sciences of the United States of America, 2012
- MicroRNA‐205–directed transcriptional activation of tumor suppressor genes in prostate cancerCancer, 2010
- MicroRNA‐205 promotes keratinocyte migrationviathe lipid phosphatase SHIP2The FASEB Journal, 2010
- microRNA-205 Regulates HER3 in Human Breast CancerCancer Research, 2009
- miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase CεCancer Research, 2009
- Suppression of cell growth and invasion by miR-205 in breast cancerCell Research, 2009
- Widespread deregulation of microRNA expression in human prostate cancerOncogene, 2007
- Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisationBritish Journal of Cancer, 2007
- Extensive modulation of a set of microRNAs in primary glioblastomaBiochemical and Biophysical Research Communications, 2005